Trial intelligence / Profile preview

Intratympanic gentamicin therapy for Meniere's disease: comparison of two regimes

2006-005913-37Phase 3Completed

Sponsor
University Medical Center Utrecht
Start
Dec 2008
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, randomised trial of gentamicin in Meniere Disease (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Dizziness Handicap Inventory (DHI) score. Started Dec 2008; status: completed.

02

Drugs

gentamicin
03

Conditions

Meniere Disease

Beyond the preview

Go deeper on 2006-005913-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005913-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call